|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | University Hospital, Toulouse |
|---|---|
| Collaborator: |
Ministry of Health, France |
| Information provided by: | University Hospital, Toulouse |
| ClinicalTrials.gov Identifier: | NCT00222040 |
Purpose
To determine whether transcranial 2-MHz ultrasound combined with intravenous administration of microbubbles improves early recanalization in patients with acute ischemic stroke caused by middle cerebral artery (MCA) proximal occlusion treated with intravenous alteplase within 3 hours of symptom onset.
| Condition | Intervention | Phase |
|---|---|---|
|
Acute Ischemic Stroke |
Radiation: Ultrasound Drug: Levovist |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study |
| Enrollment: | 20 |
| Study Start Date: | June 2004 |
| Study Completion Date: | June 2004 |
| Primary Completion Date: | June 2004 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1: Experimental
Levovist
|
Radiation: Ultrasound
2-MHz, low intensity transcranial ultrasound
Drug: Levovist
D-Galactose and palmitic palmitique intravenous 4 g
|
|
2: No Intervention
No specific intervention
|
Proximal MCA occlusion is recognized using MR or CT angiography performed before inclusion. All patients are treated with alteplase according to current guidelines. In addition, patients randomized in the active group are continuously exposed to transcranial 2-MHz ultrasound for 1 hour combined with intravenous administration of microbubbles. Controls are only treated with alteplase. The ultrasound beam is positioned at the thrombus/blood flow interface using color-coded sonography. Galactose-based microbubbles are administered via continuous intravenous infusion over 40 min.
Early recanalization is assessed using MR or CT angiography 4 to 8 hours after symptom onset. The evaluation of angiograms is performed by 2 neuroradiologists blinded to group of randomization and clinical details. The primary outcome measure is the rate of early recanalization. Recanalization is assessed using the TIMI classification. Secondary endpoints include the rate of symptomatic intracerebral hemorrhage, mortality, and functional outcome on the modified Rankin scale at 3 months.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contacts and Locations| France | |
| Service de Neurologie Vasculaire, University Hospital | |
| TOULOUSE, France, 31059 | |
| Service de Neurologie | |
| BESANCON, France, 25030 | |
| Service de Neurologie, University Hospital | |
| Tours, France, 37044 | |
| Service de Neurologie, Hôpital Gui de Chauliac | |
| MONTPELLIER, France, 34295 | |
| Service de Neurologie, Hôpital Sainte Anne | |
| PARIS, France, 75674 | |
| Principal Investigator: | LARRUE Vincent, MD | University Hospital Toulouse, FRANCE |
More Information
| Responsible Party: | University Hospital Toulouse ( LLAU Marie-Elise ) |
| Study ID Numbers: | 0302208 |
| Study First Received: | September 15, 2005 |
| Last Updated: | June 20, 2008 |
| ClinicalTrials.gov Identifier: | NCT00222040 History of Changes |
| Health Authority: | France: Afssaps - French Health Products Safety Agency |
|
Stroke thrombolysis ultrasound microbubbles alteplase |
|
Nervous System Diseases Stroke Vascular Diseases Central Nervous System Diseases |
Cardiovascular Diseases Brain Diseases Cerebrovascular Disorders |